Myeldysplastic Syndrome (MDS)
3 clinical trials · Condition
◉ Watch Myeldysplastic Syndrome (MDS)
| Record | Firm | Date |
|---|---|---|
| Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia (NCT01629082) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-06-06 |
Track Myeldysplastic Syndrome (MDS) automatically
Every clearance here is in the API, with alerts when new ones post.